Navigation Links
FDA Reviewing Biomoda Submission for Cancer Screening Study
Date:8/4/2008

ALBUQUERQUE, N.M., Aug. 4 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com), a development stage medical diagnostics company, submitted to the FDA a pre-IDE (Investigational Device Exemption) protocol for a clinical study using Biomoda's proprietary assay for detection of early lung cancer in veterans. The New Mexico state legislature allocated more than $1.6 million over two years towards the study that will screen more than 2000 veterans.

"This is an essential step in study development," said John Cousins, President of Biomoda. "Approval by the FDA of the study design this year allows us to move forward quickly to prove the efficacy of the assay. Approval by the Agency of the results of this study that we expect early next year will provide us the ability to market our assay commercially."

Biomoda's patented technology is designed for early lung cancer screening of large populations at a reasonable cost. The non-invasive test, originally developed at Los Alamos National Laboratory, allows clinicians to identify cancerous or aberrant cells extracted from samples of lung sputum; cancerous cells in the sputum exposed to the assay glow red under fluorescent light and can be detected under a microscope.

Earlier this year, Biomoda and the New Mexico Institute of Mining and Technology announced their partnership with the New Mexico Department of Veterans Services to conduct a two-phase study of the state's veterans. The initial phase will screen 225 veterans; a second phase will test more than 2000 veterans for lung cancer using Biomoda's non-invasive patented assay.

Lung cancer claims more lives than any other cancer. The expected five-year survival rate for all patients diagnosed with lung cancer is 15%; the five-year survival rate for cases detected when the disease is still localized is 50 percent. Presently, only 16% of lung cancer cases ar
'/>"/>

SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Small Business Innovation Research Program Awards Grant to Biomoda
2. Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer at Annual SWARM Meeting
3. AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
4. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
5. Synbiotics Corporation Announces Human Submission for FluDetect(R)
6. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
7. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
8. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
9. Indevus Announces Submission of New Drug Application
10. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
11. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  ResMed Inc. (NYSE: RMD ) ... fiscal year ended June 30, 2014.  Revenue for the quarter ... 30, 2013 (a 1 percent decrease on a constant currency ... percent compared to the quarter ended June 30, 2013. Diluted ... of 22 percent compared to the quarter ended June 30, ...
(Date:7/31/2014)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. ... NY Wednesday, August 13, 2014 at 9.10 a.m. ... New York, NY Thursday, September 4, 2014 ... Webcasts To access the live webcasts for these events, please ...
(Date:7/31/2014)...  UBM Medica US announces that Cancer ... presents exclusive slide shows dealing with communication in the ... care. Cancer Network, the online ... blogs, and podcasts about the latest clinical findings. Among ... , End-of-life care is challenging for even the ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Cepheid to Webcast Upcoming Financial Presentations 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3
(Date:8/1/2014)... Gerontological Society of America (GSA) the ... aging has chosen Sean P. Curran, PhD, of ... of the Nathan Shock New Investigator Award. , This ... knowledge about aging through basic biological research. It was ... founding member of GSA and pioneer in gerontological research ...
(Date:8/1/2014)... 1, 2014)The use of electronic reminders such as text ... surgical patients to adhere to a preadmission antiseptic showering ... infections (SSIs), according to a first-of-its-kind study published in ... American College of Surgeons . , Each year approximately ... approaching nearly 100,000 according to data sources cited by ...
(Date:8/1/2014)... Plains, NJ (PRWEB) August 01, 2014 ... interactive web portal that aims to empower patients ... role in their health care by providing easy, ... Patient Portal gives patients instant, web-based access to ... laboratory and radiology results, medications, allergies, demographic information, ...
(Date:8/1/2014)... 2014 Ticket Down is a reputable source ... Farms in Knoxville/Greenback, TN; Ingram Farms in Auburn/Opelika, AL; Cross ... Archer/Gainesville, FL. Luke Bryan is currently out on his summer ... Cole Swindell. Bryan is responsible for one of the most ... this year, just because the summer is over doesn’t mean ...
(Date:8/1/2014)... City, NY (PRWEB) August 01, 2014 With ... two incomes, and the convenience of processed, microwavable dinners, it ... Diet Doc does not offer patients a mere quick fix ... helping everyone, in any part of the country, get slimmer ... if they offer patients the tools and education on ...
Breaking Medicine News(10 mins):Health News:Curran to receive GSA's 2014 Nathan Shock New Investigator Award 2Health News:Electronic reminders can help patients prevent surgical site infections 2Health News:Electronic reminders can help patients prevent surgical site infections 3Health News:Chilton Medical Center Launches Online Patient Portal 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 3Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 4Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 3
... , , MONDAY, Sept. 28 (HealthDay News) -- Women ... risk of developing atrial fibrillation, a potentially life-threatening irregular ... atrial fibrillation was 3.6 percent among people with type ... metabolic condition was only 2.5 percent, according to the ...
... have used nanomaterials to develop a microchip sensitive enough ... patient,s cancer so that the disease can be detected ... reported Sept. 27 in Nature Nanotechnology heralds ... "This remarkable innovation is an indication that the ...
... Ltd., a privately held medical device company focused on ... for the treatment of cancer, announced the completion of ... round included Pfizer Inc, Johnson & Johnson Development Corporation ... Pfizer, Johnson & Johnson Development Corporation and Index have ...
... new poll by the Harvard School of Public Health and The ... the state,s health reform legislation, which was enacted in 2006, support ... and 13% are not sure. The level of public support for ... saying they support the law in 2008 to 59% in the ...
... On October 2nd, 2009, Henry Gabelnick PhD, Executive ... Alan F. Guttmacher lecture at the 2009 Association ... Angeles, California. Reproductive Health 2009 is a partnership ... Parenthood Federation of America National Medical Committee, and the ...
... ... to the advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, Tenn. (PRWEB) September 28, 2009 ... a healthcare communications company. The board provides guidance on innovative ways to leverage PerfectServe,s ...
Cached Medicine News:Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 2Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 3Health News:U of T researchers create microchip that can detect type and severity of cancer 2Health News:NovoCure Ltd. announces closing of financing round 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 3Health News:CONRAD executive director to give Guttmacher lecture at Reproductive Health 2009 2Health News:William Fuchs Named to PerfectServe Advisory Board 2
Galaxy Single Piece PMMA Lens with UV Absorber....
Liberty Single Piece PMMA Lens with UV Absorber....
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: